AdipoQ T45 G and G276 T Polymorphisms and Susceptibility to Nonalcoholic Fatty Liver Disease Among Asian Populations: A Meta-Analysis and Meta-Regression

Journal of Clinical Laboratory Analysis

Volumn 30, Issue 1, 2016, Pages 47-57

  Wang, Bai Fang ^a   Wang, Ying ^a   Ao, Ran ^a   Tong, Jing ^a   Wang, Bing Yuan ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Adiponectin; Meta analysis; Meta regression; Nonalcoholic fatty liver disease; Single nucleotide polymorphism

Indexed keywords

ADIPOQ GENE; ADULT; ALLELE; ARTICLE; ASIAN; CONTROLLED STUDY; FEMALE; GENE; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; NONALCOHOLIC FATTY LIVER; REGRESSION ANALYSIS; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; ASIAN CONTINENTAL ANCESTRY GROUP; BIOLOGICAL MODEL; CASE CONTROL STUDY; DATA BASE; GENETIC ASSOCIATION STUDY; GENETIC HETEROGENEITY; GENETIC PREDISPOSITION; GENETICS; META ANALYSIS; MULTIVARIATE ANALYSIS;

ADIPONECTIN; ADIPOQ PROTEIN, HUMAN;

ADIPONECTIN; ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; DATABASES AS TOPIC; GENETIC ASSOCIATION STUDIES; GENETIC HETEROGENEITY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MODELS, GENETIC; MULTIVARIATE ANALYSIS; NON-ALCOHOLIC FATTY LIVER DISEASE; POLYMORPHISM, SINGLE NUCLEOTIDE; REGRESSION ANALYSIS;

EID: 84954055755     PISSN: 08878013     EISSN: 10982825     Source Type: Journal    
DOI: 10.1002/jcla.21814     Document Type: Article

References (38)

1. Vernon G, Baranova A, Younossi ZM. Systematic review: The epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Aliment Pharmacol Ther 2011;34:274-285.
2. Manrique-Garcia E, Sidorchuk A, Hallqvist J, Moradi T. Socioeconomic position and incidence of acute myocardial infarction: A meta-analysis. J Epidemiol Community Health 2011;65:301-309.
3. Erickson SK. Nonalcoholic fatty liver disease. J Lipid Res 2009;50 Suppl:S412-416.
4. Kumashiro N, Erion DM, Zhang D, et al. Cellular mechanism of insulin resistance in nonalcoholic fatty liver disease. Proc Natl Acad Sci USA 2011;108:16381-16385.
5. Vanni E, Bugianesi E, Kotronen A, et al. From the metabolic syndrome to NAFLD or vice versa? Dig Liver Dis 2010;42:320-330.
6. Day CP. Genetic and environmental susceptibility to non-alcoholic fatty liver disease. Dig Dis 2010;28:255-260.
7. Licastro F, Chiappelli M, Porcellini E, et al. Gene-gene and gene-clinical factors interaction in acute myocardial infarction: A new detailed risk chart. Curr Pharm Des 2010;16:783-788.
8. Duvnjak M, Barsic N, Tomasic V, Lerotic I. Genetic polymorphisms in non-alcoholic fatty liver disease: Clues to pathogenesis and disease progression. World J Gastroenterol 2009;15:6023-6027.
9. Schwimmer JB, Celedon MA, Lavine JE, et al. Heritability of nonalcoholic fatty liver disease. Gastroenterology 2009;136:1585-1592.
10. Trujillo ME, Scherer PE. Adiponectin - Journey from an adipocyte secretory protein to biomarker of the metabolic syndrome. J Intern Med 2005;257:167-175.
11. Cooney MT, Dudina A, de Bacquer D, et al. HDL cholesterol protects against cardiovascular disease in both genders, at all ages and at all levels of risk. Atherosclerosis 2009;206:611-616.
12. Thompson JF, Durham LK, Lira ME, Shear C, Milos PM. CETP polymorphisms associated with HDL cholesterol may differ from those associated with cardiovascular disease. Atherosclerosis 2005;181:45-53.
13. Ridker PM, Pare G, Parker AN, et al. Polymorphism in the CETP gene region, HDL cholesterol, and risk of future myocardial infarction: Genomewide analysis among 18 245 initially healthy women from the Women's Genome Health Study. Circ Cardiovasc Genet 2009;2:26-33.
14. Takahashi M, Arita Y, Yamagata K, et al. Genomic structure and mutations in adipose-specific gene, adiponectin. Int J Obes Relat Metab Disord 2000;24:861-868.
15. Stumvoll M, Tschritter O, Fritsche A, et al. Association of the T-G polymorphism in adiponectin (exon 2) with obesity and insulin sensitivity: Interaction with family history of type 2 diabetes. Diabetes 2002;51:37-41.
16. Szopa M, Malczewska-Malec M, Kiec-Wilk B, et al. Variants of the adiponectin gene and type 2 diabetes in a Polish population. Acta Diabetol 2009;46:317-322.
17. Al-Daghri NM, Al-Attas OS, Alokail MS, et al. Adiponectin gene polymorphisms (T45G and G276T), adiponectin levels and risk for metabolic diseases in an Arab population. Gene 2012;493:142-147.
18. Wong VW, Wong GL, Tsang SW, et al. Genetic polymorphisms of adiponectin and tumor necrosis factor-alpha and nonalcoholic fatty liver disease in Chinese people. J Gastroenterol Hepatol 2008;23:914-921.
19. Tokushige K, Hashimoto E, Noto H, et al. Influence of adiponectin gene polymorphisms in Japanese patients with non-alcoholic fatty liver disease. J Gastroenterol 2009;44:976-982.
20. Zhou YJ, Li YY, Nie YQ, et al. Influence of polygenetic polymorphisms on the susceptibility to non-alcoholic fatty liver disease of Chinese people. J Gastroenterol Hepatol 2010;25:772-777.
21. Gupta AC, Misra R, Sakhuja P, et al. Association of adiponectin gene functional polymorphisms (-11377C/G and +45T/G) with nonalcoholic fatty liver disease. Gene 2012;496:63-67.
22. Wang ZL, Xia B, Shrestha U, et al. Correlation between adiponectin polymorphisms and non-alcoholic fatty liver disease with or without metabolic syndrome in Chinese population. J Endocrinol Invest 2008;31:1086-1091.
23. da Costa BR, Cevallos M, Altman DG, Rutjes AW, Egger M. Uses and misuses of the STROBE statement: Bibliographic study. BMJ Open 2011;1:e000048.
24. Jackson D, White IR, Riley RD. Quantifying the impact of between-study heterogeneity in multivariate meta-analyses. Stat Med 2012;31:3805-3820.
25. Peters JL, Sutton AJ, Jones DR, Abrams KR, Rushton L. Comparison of two methods to detect publication bias in meta-analysis. JAMA 2006;295:676-680.
26. Ioannidis JP, Patsopoulos NA, Rothstein HR. Reasons or excuses for avoiding meta-analysis in forest plots. BMJ 2008;336:1413-1415.
27. Zintzaras E, Ioannidis JP. HEGESMA: Genome search meta-analysis and heterogeneity testing. Bioinformatics 2005;21:3672-3673.
28. Fan GL, JIng LH, Yi JP. Association of adiponectin G276T gene polymorphism with PCOS patients complicated with nonalcoholic fatty liver disease. Hebei Med J 2011;33:688-690.
29. Huang CM, Li YY, Zhou YJ, Nie YQ, Du YL. Correlation between adiponectin gene polymorphisms and susceptibility of non-alcoholic fatty liver disease. Academic J Guangzhou Med Col 2010;38:1-5.
30. Musso G, Gambino R, De Michieli F, et al. Adiponectin gene polymorphisms modulate acute adiponectin response to dietary fat: Possible pathogenetic role in NASH. Hepatology 2008;47:1167-1177.
31. Shi SL, Nie YQ, Li YY, Zhou YJ, Du YL. Association of T45G polymorphism in exon 2 of adiponectin gene with non-alcoholic fatty liver disease. Academic J Guangzhou Med Col 2005;33:1-3.
32. Zhang ZS, Zhou YJ, Li YY, Du YL, Cao CY. The correlation of the adiponectin gene tagging single nucleotide polymorphism with non-alcoholicfatty liver disease. Academic J Guangzhou Med Col 2012;33:3225-3229.
33. Ouchi N, Parker JL, Lugus JJ, Walsh K. Adipokines in inflammation and metabolic disease. Nat Rev Immunol 2011;11:85-97.
34. Smith BW, Adams LA. Non-alcoholic fatty liver disease. Crit Rev Clin Lab Sci 2011;48:97-113.
35. Matsuzawa Y. Adiponectin: A key player in obesity related disorders. Curr Pharm Des 2010;16:1896-1901.
36. Wang Y, Zhou M, Lam KS, Xu A. Protective roles of adiponectin in obesity-related fatty liver diseases: Mechanisms and therapeutic implications. Arq Bras Endocrinol Metabol 2009;53:201-212.
37. Polyzos SA, Toulis KA, Goulis DG, Zavos C, Kountouras J. Serum total adiponectin in nonalcoholic fatty liver disease: A systematic review and meta-analysis. Metabolism 2011;60:313-326.
38. Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: A proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000;283:2008-2012.